EE9900348A - Asendatud (1,3-bis (tsükloheksüülmetüül)-1,2,3,6-tetrahüdro- 2,6-diokso-9H-puriin-8-üül)fenüülderivaadid, nende valmistamine ja kasutamine põletikuliste seisundite ja immuunhaiguste raviks - Google Patents

Asendatud (1,3-bis (tsükloheksüülmetüül)-1,2,3,6-tetrahüdro- 2,6-diokso-9H-puriin-8-üül)fenüülderivaadid, nende valmistamine ja kasutamine põletikuliste seisundite ja immuunhaiguste raviks

Info

Publication number: EE9900348A
Authority: EE; Estonia
Prior art keywords: purin; cyclohexylmethyl; dioxo; tetrahydro; bis
Prior art date: 1997-02-14

Application number

EEP199900348A

Other languages

English (en)

Estonian (et)

Inventor

Alan Livingston Douglas

Mary Daluge Susan

Wolberg Gerald

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-14

Filing date

1998-02-12

Publication date

2000-02-15

1998-02-12 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2000-02-15 Publication of EE9900348A publication Critical patent/EE9900348A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP199900348A 1997-02-14 1998-02-12 Asendatud (1,3-bis (tsükloheksüülmetüül)-1,2,3,6-tetrahüdro- 2,6-diokso-9H-puriin-8-üül)fenüülderivaadid, nende valmistamine ja kasutamine põletikuliste seisundite ja immuunhaiguste raviks EE9900348A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9703044.9A GB9703044D0 (en)	1997-02-14	1997-02-14	Phenyl xanthine esters and amides
PCT/EP1998/000784 WO1998035966A1 (en)	1997-02-14	1998-02-12	Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders

Publications (1)

Publication Number	Publication Date
EE9900348A true EE9900348A (et)	2000-02-15

Family

ID=10807635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900348A EE9900348A (et)	1997-02-14	1998-02-12	Asendatud (1,3-bis (tsükloheksüülmetüül)-1,2,3,6-tetrahüdro- 2,6-diokso-9H-puriin-8-üül)fenüülderivaadid, nende valmistamine ja kasutamine põletikuliste seisundite ja immuunhaiguste raviks

Country Status (37)

Country	Link
US (3)	US6355646B1 (xx)
EP (1)	EP0970081B1 (xx)
JP (1)	JP2001511792A (xx)
KR (1)	KR100522639B1 (xx)
CN (1)	CN1140527C (xx)
AP (1)	AP1000A (xx)
AR (1)	AR011441A1 (xx)
AT (1)	ATE304542T1 (xx)
AU (1)	AU754456B2 (xx)
BG (1)	BG103722A (xx)
BR (1)	BR9807682B1 (xx)
CA (1)	CA2280730C (xx)
CO (1)	CO4940444A1 (xx)
CZ (1)	CZ298764B6 (xx)
DE (1)	DE69831559T2 (xx)
DK (1)	DK0970081T3 (xx)
EA (1)	EA199900648A1 (xx)
EE (1)	EE9900348A (xx)
ES (1)	ES2249822T3 (xx)
GB (1)	GB9703044D0 (xx)
HR (1)	HRP980077A2 (xx)
HU (1)	HU225962B1 (xx)
ID (1)	ID22770A (xx)
IL (1)	IL131179A (xx)
IS (1)	IS5144A (xx)
MY (1)	MY118545A (xx)
NO (1)	NO325685B1 (xx)
NZ (1)	NZ336923A (xx)
PE (1)	PE58899A1 (xx)
PL (1)	PL188018B1 (xx)
SK (1)	SK110399A3 (xx)
TR (1)	TR199901942T2 (xx)
TW (1)	TW520371B (xx)
UA (1)	UA57767C2 (xx)
WO (1)	WO1998035966A1 (xx)
YU (1)	YU38399A (xx)
ZA (1)	ZA981175B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9703044D0 (en) *	1997-02-14	1997-04-02	Glaxo Group Ltd	Phenyl xanthine esters and amides
GB9817623D0 (en)	1998-08-13	1998-10-07	Glaxo Group Ltd	Pharmaceutical compounds
US6545002B1 (en) *	1999-06-01	2003-04-08	University Of Virginia Patent Foundation	Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) *	2000-02-15	2005-07-08	Hoechst Marion Roussel Inc	Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
AU2002252134A1 (en) *	2001-02-28	2002-09-12	Smithkline Beecham Corporation	Methods of treating irritable bowel syndrome and functional dyspepsia
US20080318983A1 (en) *	2001-11-09	2008-12-25	Rao Kalla	A2b adenosine receptor antagonists
US7125993B2 (en) *	2001-11-09	2006-10-24	Cv Therapeutics, Inc.	A2B adenosine receptor antagonists
US20040072848A1 (en) *	2002-02-26	2004-04-15	Huber Brian E	Methods of treating irritable bowel syndrome and functional dyspepsia
EA018427B1 (ru) *	2003-12-16	2013-07-30	Нектар Терапьютикс	Химически модифицированный налоксон
AU2012227249B2 (en) *	2003-12-16	2014-10-02	Nektar Therapeutics	Chemically modified small molecules
US20060182692A1 (en)	2003-12-16	2006-08-17	Fishburn C S	Chemically modified small molecules
WO2005102976A1 (en) *	2004-04-21	2005-11-03	Smithkline Beecham Corporation	Process for preparing nonaethylene glycol monomethyl ether
CN101043889B (zh) *	2004-09-01	2010-11-03	吉利德帕洛阿尔托股份有限公司	A2b腺苷受体拮抗剂在制备促使伤口愈合的药物中的应用
US20070059740A1 (en) *	2005-08-26	2007-03-15	Linden Joel M	Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) *	2007-01-04	2012-06-05	University Of Virginia Patent Foundation	Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8510758D0 (en)	1985-04-27	1985-06-05	Wellcome Found	Compounds
US4968672A (en)	1987-01-02	1990-11-06	The United States Of America As Represented By The Department Of Health And Human Services	Adenosine receptor prodrugs
US5015647A (en)	1987-04-24	1991-05-14	Burroughs Wellcome Co.	Method for treating viral infections
GB8826595D0 (en)	1988-11-14	1988-12-21	Beecham Wuelfing Gmbh & Co Kg	Active compounds
GB8906792D0 (en)	1989-03-23	1989-05-10	Beecham Wuelfing Gmbh & Co Kg	Treatment and compounds
NZ240644A (en)	1990-11-21	1994-08-26	Smithkline Beecham Corp	Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
GB9210839D0 (en) *	1992-05-21	1992-07-08	Smithkline Beecham Plc	Novel compounds
TW252044B (xx)	1992-08-10	1995-07-21	Boehringer Ingelheim Kg
JP2613355B2 (ja)	1992-09-28	1997-05-28	協和醗酵工業株式会社	パーキンソン氏病治療剤
GB9415529D0 (en)	1994-08-01	1994-09-21	Wellcome Found	Phenyl xanthine derivatives
DE19535504A1 (de)	1995-09-25	1997-03-27	Bayer Ag	Substituierte Xanthine
DK0812844T3 (da)	1996-06-07	2003-02-17	Hoechst Ag	Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling
GB9703044D0 (en) *	1997-02-14	1997-04-02	Glaxo Group Ltd	Phenyl xanthine esters and amides
US6117878A (en)	1998-02-24	2000-09-12	University Of Virginia	8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
WO1999043673A1 (fr)	1998-02-26	1999-09-02	Zenyaku Kogyo Kabushiki Kaisha	Derives de 1-aza-indolizine
GB9817623D0 (en) *	1998-08-13	1998-10-07	Glaxo Group Ltd	Pharmaceutical compounds
IL150368A0 (en)	1999-12-23	2002-12-01	Nitromed Inc	Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
US6751206B1 (en) *	2000-06-29	2004-06-15	Qualcomm Incorporated	Method and apparatus for beam switching in a wireless communication system

1997
- 1997-02-14 GB GBGB9703044.9A patent/GB9703044D0/en active Pending
1998
- 1998-02-11 PE PE1998000099A patent/PE58899A1/es not_active Application Discontinuation
- 1998-02-11 CO CO98007044A patent/CO4940444A1/es unknown
- 1998-02-11 MY MYPI98000546A patent/MY118545A/en unknown
- 1998-02-12 JP JP53534098A patent/JP2001511792A/ja not_active Ceased
- 1998-02-12 ID IDW990879A patent/ID22770A/id unknown
- 1998-02-12 ES ES98908090T patent/ES2249822T3/es not_active Expired - Lifetime
- 1998-02-12 BR BRPI9807682-5A patent/BR9807682B1/pt not_active IP Right Cessation
- 1998-02-12 EE EEP199900348A patent/EE9900348A/xx unknown
- 1998-02-12 KR KR10-1999-7007276A patent/KR100522639B1/ko not_active Expired - Fee Related
- 1998-02-12 AU AU66221/98A patent/AU754456B2/en not_active Ceased
- 1998-02-12 DK DK98908090T patent/DK0970081T3/da active
- 1998-02-12 PL PL98335135A patent/PL188018B1/pl unknown
- 1998-02-12 AT AT98908090T patent/ATE304542T1/de active
- 1998-02-12 EP EP98908090A patent/EP0970081B1/en not_active Expired - Lifetime
- 1998-02-12 AP APAP/P/1999/001622A patent/AP1000A/en active
- 1998-02-12 IL IL13117998A patent/IL131179A/en not_active IP Right Cessation
- 1998-02-12 US US09/367,313 patent/US6355646B1/en not_active Expired - Lifetime
- 1998-02-12 CN CNB988039419A patent/CN1140527C/zh not_active Expired - Fee Related
- 1998-02-12 CA CA002280730A patent/CA2280730C/en not_active Expired - Fee Related
- 1998-02-12 HU HU0000894A patent/HU225962B1/hu not_active IP Right Cessation
- 1998-02-12 CZ CZ0288799A patent/CZ298764B6/cs not_active IP Right Cessation
- 1998-02-12 NZ NZ336923A patent/NZ336923A/en unknown
- 1998-02-12 YU YU38399A patent/YU38399A/sh unknown
- 1998-02-12 ZA ZA9801175A patent/ZA981175B/xx unknown
- 1998-02-12 TR TR1999/01942T patent/TR199901942T2/xx unknown
- 1998-02-12 EA EA199900648A patent/EA199900648A1/ru unknown
- 1998-02-12 DE DE69831559T patent/DE69831559T2/de not_active Expired - Lifetime
- 1998-02-12 SK SK1103-99A patent/SK110399A3/sk unknown
- 1998-02-12 WO PCT/EP1998/000784 patent/WO1998035966A1/en active IP Right Grant
- 1998-02-13 AR ARP980100664A patent/AR011441A1/es active IP Right Grant
- 1998-02-13 HR HR9703044.9A patent/HRP980077A2/hr not_active Application Discontinuation
- 1998-02-24 TW TW087102632A patent/TW520371B/zh not_active IP Right Cessation
- 1998-12-02 UA UA99084601A patent/UA57767C2/uk unknown
1999
- 1999-07-30 IS IS5144A patent/IS5144A/is unknown
- 1999-08-13 NO NO19993915A patent/NO325685B1/no not_active IP Right Cessation
- 1999-09-09 BG BG103722A patent/BG103722A/xx unknown
2001
- 2001-06-01 US US09/872,546 patent/US6437124B1/en not_active Expired - Fee Related
2002
- 2002-06-17 US US10/174,414 patent/US7002012B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR011441A1 (es)	2000-08-16
NO325685B1 (no)	2008-07-07
HK1022907A1 (en)	2000-08-25
JP2001511792A (ja)	2001-08-14
AU754456B2 (en)	2002-11-14
ES2249822T3 (es)	2006-04-01
PL188018B1 (pl)	2004-11-30
US20030181471A1 (en)	2003-09-25
EA199900648A1 (ru)	2000-04-24
DK0970081T3 (da)	2006-02-06
EP0970081B1 (en)	2005-09-14
NO993915L (no)	1999-10-13
CZ288799A3 (cs)	2000-04-12
MY118545A (en)	2004-12-31
PL335135A1 (en)	2000-04-10
NO993915D0 (no)	1999-08-13
UA57767C2 (uk)	2003-07-15
PE58899A1 (es)	1999-06-17
YU38399A (sh)	2002-06-19
WO1998035966A1 (en)	1998-08-20
SK110399A3 (en)	2000-06-12
AU6622198A (en)	1998-09-08
CA2280730A1 (en)	1998-08-20
HUP0000894A3 (en)	2002-04-29
HRP980077A2 (en)	1998-12-31
BR9807682A (pt)	2000-02-15
BG103722A (en)	2000-06-30
BR9807682B1 (pt)	2009-01-13
US6355646B1 (en)	2002-03-12
CN1140527C (zh)	2004-03-03
HUP0000894A2 (hu)	2001-05-28
TR199901942T2 (xx)	1999-12-21
KR100522639B1 (ko)	2005-10-19
EP0970081A1 (en)	2000-01-12
NZ336923A (en)	2001-02-23
GB9703044D0 (en)	1997-04-02
TW520371B (en)	2003-02-11
AP9901622A0 (en)	1999-09-30
ATE304542T1 (de)	2005-09-15
IL131179A0 (en)	2001-01-28
DE69831559D1 (de)	2005-10-20
KR20000071010A (ko)	2000-11-25
CN1252071A (zh)	2000-05-03
AP1000A (en)	2001-08-11
ID22770A (id)	1999-12-09
IS5144A (is)	1999-07-30
CA2280730C (en)	2006-10-10
CO4940444A1 (es)	2000-07-24
US7002012B2 (en)	2006-02-21
ZA981175B (en)	1999-08-12
CZ298764B6 (cs)	2008-01-23
DE69831559T2 (de)	2006-06-14
IL131179A (en)	2004-05-12
HU225962B1 (en)	2008-01-28
US6437124B1 (en)	2002-08-20

Publication	Publication Date	Title
EE9900348A (et)	2000-02-15	Asendatud (1,3-bis (tsükloheksüülmetüül)-1,2,3,6-tetrahüdro- 2,6-diokso-9H-puriin-8-üül)fenüülderivaadid, nende valmistamine ja kasutamine põletikuliste seisundite ja immuunhaiguste raviks
FI944549A7 (fi)	1994-11-30	Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
BR9106864A (pt)	1993-07-20	Composicoes de liberacao prolongada para o tratamento de doencas periodontais
KR100344712B1 (ko)	2002-12-05	알러지성및염증성질환의치료에유용한화합물
FI930747A7 (fi)	1993-03-30	Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI963630A7 (fi)	1996-09-13	IFN-beta:n uusia muteiineja
DE69130089D1 (de)	1998-10-08	Hemmung der menschlichen Serumalbuminfärbung
FI935887A7 (fi)	1994-06-29	Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö
DE69027170D1 (de)	1996-07-04	Uracilderivate, ihre Herstellung und ihre Verwendung
FI924118A7 (fi)	1992-09-15	Kinoksaliiniyhdisteet ja niiden valmistus ja käyttö
FI913067A7 (fi)	1991-12-26	Bisfosfonihappojohdannaiset, niiden valmistus ja käyttö
IT1297205B1 (it)	1999-08-03	Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT1234230B (it)	1992-05-06	Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
FI925544A7 (fi)	1992-12-07	Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
FI925850A7 (fi)	1993-06-28	Pyridyylitiatsolidinikarboksyylihapon amidijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt
FI945438A7 (fi)	1994-11-18	N-/N'-(5-amino-4-hydroksiasyloyyli)-alfa aminoasyloyyli/substituoidut heterosyklit ja niiden käyttö antiviraalisina aineina
ITMI912290A0 (it)	1991-08-27	Miscele di n-alchilftalimmidi, loro preparazione e loro impiego
FI925546A7 (fi)	1992-12-07	Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
SI0970081T1 (sl)	2006-02-28	Substituirani (1,3-bis(cikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenilni derivati, njihova priprava in njihova uporaba pri zdravljenju vnetnih stanj in imunskih motenj
EE03796B1 (et)	2002-08-15	3,5-difluoropüridiinid, nende valmistamismeetod, herbitsiidne kompositsioon, nende kasutamine ja vaheühend
FI911084A7 (fi)	1991-09-07	5-fenyyli-1H-pyrazoli-4-propionihappojohdannaisia, niiden valmistus jakäyttö
IT8822858A0 (it)	1988-12-05	Composizioni per la riduzione di flebectasie e procedimento per la loro preparazione
FI935915L (fi)	1994-07-01	2-tienyyli-imidatso(2,1-b)bentsotiatsol-3-etikkahappojohdannaiset, niiden valmistus ja terapeuttinen käyttö
IT9036120V0 (it)	1990-11-27	Struttura di pantaloni perfezionata
IT9040160A1 (it)	1992-06-07	Tecnica di applicazione di smalti ceramici spatolati manualmente in bassorilievo